January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

Leading American genomic sequencing firm Illumina says it is evaluating Beijing’s announcement with hope of ‘positive ...

European equities traded in the US as American depositary receipts were higher late Thursday morning, rising 0.68% to 1,391.74 on the S&P Europe Select ADR Index. From continental Europe, the gainers ...

AbbVie took the top spot with its acquisition of American biotech Nimble Therapeutics for $200 million. The pharma giant will get a hold of Nimble’s oral peptide IL23R inhibitor, which is currently in ...

In this opinion piece, Sylvia Wulf, the Biotechnology Innovation Organization’s interim head of agriculture and environment, ...

Evaxion Biotech A/S announced the pricing of a public offering of 3,997,361 American Depositary Shares (ADSs) and accompanying warrants, priced at $2.71 per ADS. Notably, the MSD Global Health ...

The biotech entrepreneur and former presidential hopeful is expected to announce his campaign formally this month ...

The funds will support the development of Ascentage’s pipeline, including its lead candidate olverembatinib to treat blood ...

Evaxion Biotech A/S announced that it has implemented a change in the ratio of its American Depositary Shares (ADSs) from one ADS representing ten ordinary shares to one ADS representing fifty ...

The UK biotech sector raised £3.5bn in 2024, marking a 94% increase from the previous year, according to the BioIndustry ...

After hours: February 3 at 4:44:54 PM EST Loading Chart for LEGN ...